DPLO - Diplomat Pharmacy, Inc.

NYSE - Nasdaq Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5425.41M
Enterprise Value 31.03B
Trailing P/E N/A
Forward P/E 1-12.75
PEG Ratio (5 yr expected) 10.39
Price/Sales (ttm)0.08
Price/Book (mrq)1.40
Enterprise Value/Revenue 30.19
Enterprise Value/EBITDA 612.34

Trading Information

Stock Price History

Beta (3Y Monthly) 1.11
52-Week Change 3-70.53%
S&P500 52-Week Change 33.78%
52 Week High 321.48
52 Week Low 34.17
50-Day Moving Average 35.65
200-Day Moving Average 35.54

Share Statistics

Avg Vol (3 month) 3819.99k
Avg Vol (10 day) 3949.78k
Shares Outstanding 575.83M
Float 46.37M
% Held by Insiders 123.71%
% Held by Institutions 192.71%
Shares Short (Aug 15, 2019) 48.01M
Short Ratio (Aug 15, 2019) 411.08
Short % of Float (Aug 15, 2019) 416.52%
Short % of Shares Outstanding (Aug 15, 2019) 410.57%
Shares Short (prior month Jul 15, 2019) 48.28M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin -8.94%
Operating Margin (ttm)0.29%

Management Effectiveness

Return on Assets (ttm)0.60%
Return on Equity (ttm)-89.24%

Income Statement

Revenue (ttm)5.28B
Revenue Per Share (ttm)70.85
Quarterly Revenue Growth (yoy)-9.10%
Gross Profit (ttm)376.01M
EBITDA 83.2M
Net Income Avi to Common (ttm)-471.62M
Diluted EPS (ttm)-6.33
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.77M
Total Cash Per Share (mrq)0.08
Total Debt (mrq)607.55M
Total Debt/Equity (mrq)202.88
Current Ratio (mrq)0.99
Book Value Per Share (mrq)4.00

Cash Flow Statement

Operating Cash Flow (ttm)35.14M
Levered Free Cash Flow (ttm)24.92M